Press Release

Primary Cells Market to Grow with a CAGR of 5.25% through 2029

Increasing prevalence of chronic diseases and rising drug discovery and development are factors driving the Global Primary Cells Market in the forecast period 2025-2029.

 

According to TechSci Research report, “Primary Cells Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2029”, the Global Primary Cells Market stood at USD 1.52 billion in 2023 and is anticipated to grow with a CAGR of 5.25% in the forecast period, 2025-2029. The global primary cells market has witnessed remarkable growth in recent years, driven by various factors that are reshaping the landscape of life sciences and medical research. Primary cells are non-transformed cells that are isolated directly from living tissues, offering a more accurate representation of in vivo conditions compared to immortalized cell lines. Researchers and biopharmaceutical companies have increasingly recognized the importance of primary cells in various applications, ranging from drug discovery and development to regenerative medicine. One of the primary drivers of the global primary cells market is the rising demand for personalized medicine. Personalized medicine involves tailoring medical treatment to an individual's unique genetic makeup, and primary cells play a crucial role in this approach. Researchers use primary cells to develop patient-specific models for drug screening and testing, thereby enabling the development of treatments that are more effective and with fewer side effects.

 

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Primary Cells Market

 

The prevalence of chronic diseases such as cancer, diabetes, and cardiovascular disorders is on the rise globally. This has spurred the demand for primary cells, as they are essential for studying the underlying mechanisms of these diseases, identifying potential therapeutic targets, and testing new drug candidates. Primary cell-based research is instrumental in advancing our understanding of complex diseases and developing innovative treatment options.

Regenerative medicine is a rapidly evolving field that holds the promise of repairing or replacing damaged tissues and organs. Primary cells, particularly stem cells, are critical for regenerative medicine applications. Their use in tissue engineering and organ transplantation research is driving the growth of the primary cells market. As regenerative medicine continues to gain momentum, the demand for primary cells is expected to increase further.

The pharmaceutical industry relies heavily on primary cells for drug discovery and development. Primary cell cultures are used to assess the safety and efficacy of potential drug candidates, reducing the likelihood of adverse effects in later stages of drug development. As the pharmaceutical sector continues to expand and innovate, the demand for primary cells for in vitro testing is expected to remain strong.

The Global Primary Cells Market is segmented into product, origin, end user and company.

Based on end user, the Pharma Biotech segment has emerged as the predominant market leader. Pharmaceutical and biotechnology companies are increasingly relying on primary cells to screen potential drug candidates. The ability to study the effects of drugs on primary cells in a more physiologically relevant environment can significantly reduce the failure rate in clinical trials. Stem cells, a type of primary cell, are at the forefront of regenerative medicine. The pharmaceutical and biotech industries are heavily invested in developing stem cell-based therapies to treat a wide range of diseases, such as diabetes, heart disease, and neurodegenerative disorders.

Based on region, North America segment is expected to grow during the forecast period.  North American governments, private enterprises, and funding agencies have consistently invested in research and development. The significant financial resources allocated to primary cell research and its applications have propelled the region's dominance. This investment has led to breakthroughs in cell therapy, regenerative medicine, and the development of cutting-edge therapies for various diseases.

 

Major companies operating in Global Primary Cells Market are:

  • AllCells
  • ZenBio Inc.
  • PromoCell
  • Thermo Fisher Scientific Inc.
  • Cell Biologics Inc.
  • STEMCELL Technologies Inc.
  • Merck KGaA
  • American Type Culture Collection (ATCC)

 

Download Free Sample Report

Customers can also request for 10% free customization on this report

 

“The global primary cells market is experiencing robust growth, primarily driven by the increasing demand for personalized medicine, the prevalence of chronic diseases, advancements in regenerative medicine, and the expanding biopharmaceutical industry. Additionally, technological innovations and rising investments in life sciences research are contributing to the market's momentum. As the importance of primary cells in various applications continues to grow, the market is expected to witness further expansion and innovation in the years to come, making it an exciting and dynamic sector within the life sciences industry.” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based management consulting firm.

Primary Cells Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Hematopoietic, Dermatocytes, Hepatocytes, Gastrointestinal, Lung, Renal, Heart, Musculoskeletal), By Origin (Human Primary Cells, Animal Primary Cells), By End user (Pharma Biotech, CROS, Academia), By Region and Competition 2019-2029F”, has evaluated the future growth potential of Global Primary Cells Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Primary Cells Market.

 

Contact Us-

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

M: +13322586602

Email: [email protected]

Website: www.techsciresearch.com

Relevant News